180 related articles for article (PubMed ID: 27363025)
1. Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy.
Renier C; Do J; Reyna-Neyra A; Foster D; De A; Vogel H; Jeffrey SS; Tse V; Carrasco N; Wapnir I
Oncotarget; 2016 Aug; 7(34):54811-54824. PubMed ID: 27363025
[TBL] [Abstract][Full Text] [Related]
2. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
[TBL] [Abstract][Full Text] [Related]
5. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
6. Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and NIS gene-transduced SNU-C5 colon cancer cells.
Yoon JK; Park BN; Paik JY; Jung KH; Ko BH; Lee KH
Cancer Biother Radiopharm; 2009 Apr; 24(2):201-8. PubMed ID: 19409042
[TBL] [Abstract][Full Text] [Related]
7. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
Zhang M; Guo R; Shi S; Miao Y; Zhang Y; Li B
PLoS One; 2014; 9(3):e92326. PubMed ID: 24647588
[TBL] [Abstract][Full Text] [Related]
8. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
Cho JY
Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
[TBL] [Abstract][Full Text] [Related]
9. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.
Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C; Studebaker AW
BMC Cancer; 2012 Nov; 12():508. PubMed ID: 23134812
[TBL] [Abstract][Full Text] [Related]
10. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
Trujillo MA; Oneal MJ; Davydova J; Bergert E; Yamamoto M; Morris JC
Breast Cancer Res; 2009; 11(4):R53. PubMed ID: 19635153
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
14. TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.
Schug C; Urnauer S; Jaeckel C; Schmohl KA; Tutter M; Steiger K; Schwenk N; Schwaiger M; Wagner E; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jan; 26(1):89-101. PubMed ID: 30121623
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.
Kelkar MG; Senthilkumar K; Jadhav S; Gupta S; Ahn BC; De A
Sci Rep; 2016 Jan; 6():19341. PubMed ID: 26777440
[TBL] [Abstract][Full Text] [Related]
16. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
[TBL] [Abstract][Full Text] [Related]
18. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
19. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
